The study titled "Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)" was pulled from BMJ on March 31, 2026. Shortly after its release in October 2025, multiple issues were identified concerning the study's methodology, execution, and data presentation. The journal's editors published a notice of concern in November 2025, citing potential deviations from standard research protocols.
（本文由光子星球撰写，钛媒体获准转载）
[link] [comments]。向日葵下载对此有专业解读
（央视记者 丛威娜 盛洁 报道）【责任编辑：史词】
。关于这个话题，Facebook BM账号,Facebook企业管理,Facebook商务账号提供了深入分析
State court jurist Gregory Carro had previously contemplated moving his trial to September, but only contingent upon federal prosecutors challenging Garnett's prohibition against pursuing execution. No appeal was filed.
同步到LinkedIn（新窗口开启），详情可参考WhatsApp網頁版